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Abstract  
∆hPRL is a potent human prolactin (hPRL) antagonist, engineered by the deletion 
of 12 key residues (residues 41 through 52) from wild-type hPRL. The resulting 
monomeric protein displays potent antagonist activity with little remaining agonist 
activity, however an undesirable result of this deletion is difficulty in folding, as 
evidenced by significant formation of dimeric species. The dimeric species is biologically 
inert. ∆hPRL is derived from wild-type hPRL a 199-residue single peptide protein 
containing three native disulfide bonds (C4--C11, C58--C174, C191--C199). Using mass 
spectrometric and additional biochemical techniques, we intend to determine the nature 
of the linkage found in dimeric ∆hPRL and identify key residues participating in this 
linkage. 
Recombinant ∆hPRL, methionyl protein expressed using BL-21 E. coli, was folded, and 
purified from cell lysates by ion-exchange chromatography. Monomeric and dimeric 
species were separated by size-exclusion chromatography. Both species were 
characterized by absorbance spectroscopy, luminescence spectroscopy, and intact 
accurate mass determination by electro-spray Q-TOF. Each sample was analyzed by 
SDS-PAGE under reducing (2-BME) and non-reducing conditions. Dimeric ∆hPRL was 
denatured in urea, alkylated, and digested with trypsin. Tryptic peptides were analyzed by 
MALDI-TOF and electrospray LC/MS/MS to generate peptide maps and sequence 
information. 
Accurate mass determination of intact ∆hPRL revealed that the molecular weight 
of dimeric species is twice the molecular weight of monomeric species, indicating that 
dimer is made of two constituent monomers with no sequence modification. Comparison 
of reducing and non-reducing SDS-PAGE analyses shows that dimeric species present 
after folding are resolved into purely monomeric constituents when treated with 2-BME, 
implying that dimeric linkage is due to inter-molecular disulfide bond formation. Further, 
spectroscopic variation between monomeric and dimeric species indicates that folding is 
perturbed in the dimeric species, increasing the prospect of opportunistic inter-molecular 
disulfide formation between cysteine residues. Peptide maps with approximately 70% 
coverage and sequence data resulting from tryptic digestion of alkylated dimeric ∆hPRL 
display cysteine-containing peptides in a mixture of disulfide-linked and free (alkylated) 
states, suggesting random intra-molecular and inter-molecular pairing between available 
cysteines. Observation of the disulfide-linked peptide 11-16 paired to 11-16 implies C11-
-C11 disulfide formation. This disulfide can only exist between molecules, suggesting 
that dimeric linkage is the product of intermolecular disulfide bonding between C11 
residues. 
Introduction 
 Human prolactin is a peptide hormone secreted by the anterior pituitary. Prolactin 
is historically associated with lactation since it acts as a growth factor for mammary 
epithelium, however it has also been implicated in mammary carcinogenesis (for review, 
[1]). As a possible target for treatment of breast cancer, the creation of potent prolactin 
antagonists has been the focus of much research.  
 Human prolactin is part of a super-family of structurally homologous hormones 
including human growth hormone and human placental lactogen. These molecules 
consist of four-helix bundles in an up-up-down-down order such that extensive 
unstructured regions join the c-terminal ends of helices 1 and 3 to the n-terminal ends of 
helices 2 and 4, respectively. Native wild-type human prolactin is a 199 amino acid 
peptide, joined by 3 intramolecular disulfide bonds (Fig 1). One disulfide exists on a 
small n-terminal loop, between Cys4 and Cys11. A similar disulfide is formed on a small 
c-terminal loop, between Cys191 and Cys199. A 
third disulfide is formed in a more central and 
structurally important region of the molecule, 
between Cys58 and Cys174.  
The disulfide-linked loops on either end of 
the molecule have little structural influence, but the 
n-terminal loop in particular has shown a mixed 
influence on the activity of the molecule [2]. The 
disulfide formed between Cys58 and Cys174 is 
commonly referred to as the central disulfide, and 
Figure 1: Solution structure of human 
prolactin; disulfide bonds are shown in 
gold between C4 and C11, C58 and 
C174, and C191 and C199. 
Figure 2: Solution structure of human 
prolactin; putative binding sites are 
indicated as site 1 and site 2; disulfide 
bonds are shown in yellow 
its formation is critical to successful folding and 
activity of the molecule [3].  
The mechanism by which prolactin acts to 
stimulate growth is key to understanding many 
approaches of current prolactin antagonists. Human 
prolactin acts at the cell surface of its target tissue 
by receptor dimerization (see Fig 2): prolactin is 
first bound at site 1 by a prolactin receptor; this 
binding induces a conformation change that opens 
site 2 so that a second receptor binds prolactin at 
site 2. The formation of this heterotrimeric complex 
(prolactin + 2 receptors) is essential to growth stimulation by prolactin. Further, it has 
been shown that site 2 binding is functionally coupled to site 1 binding, meaning that site 
2 binding depends on receptor occupation of site 1 [4].     
Delta prolactin is a potent prolactin antagonist developed by the Brooks lab, 
engineered by the deletion of 12 key residues from wild-type human prolactin [5]. As 
shown in Figure 1, residues Asp41 through Thr52 (in red) were removed by site-directed 
mutagenesis from the region c-terminal to helix 1. This deletion results in a 14,000-fold 
reduction of activity compared to wild-type prolactin. It is likely that the large loss of 
activity is due to the functional de-coupling of site 1 and site 2 binding by removal of the 
coupling residues 41-52. 
Although delta prolactin displays promising prolactin antagonism, it also displays 
marked difficulty in folding, as evidenced by the observation of dimeric and aggregate 
forms during isolation. It is therefore worthwhile to determine key residues involved in 
dimeric delta prolactin linkage, and the nature of their linkage. 
Methods  
Expression 
 Expression was carried out using previously described protocols [6,7]. The 
negative strand of a pT7-7f(-) phagemid – a modification [7] of the pT7-7 vector 
provided by S. Tabor, Harvard Medical School, Boston, MA – was used for cloning, 
production of ssDNA, and protein expression in Escherichia coli strains DH5α, RZ1032, 
and BL21(DE3), respectively. Mutagenesis was performed by the Kunkel method [8] 
from wild-type phagemids containing an n-terminal Met codon. The double-stranded 
DNA plasmid containing the sequence for delta prolactin was transformed into BL-
21(DE3) E. coli, which were then plated onto LB-agar plates containing ampicillin. 
Colonies were selected and grown to in 1 L LB containing ampicillin at 37 ˚C. Upon 
reaching an approximate OD600 of 0.3, expression was induced by addition of IPTG, and 
cultures were allowed to grow an additional four hours.  
Isolation 
Following expression, protein was extracted into 100 ml of 100 mM Tris buffer 
(pH 11.5) containing 4.5 M urea, and allowed to air oxidize for 2 days at 4˚C. The 
oxidized protein was then dialyzed against 20 mM Tris buffer (4 L, pH 7.5) for six 
exchanges. During this dialysis, we predict that the protein folds to its native form by first 
gaining helical structure with the rapid loss of urea, then forming increasingly stable 
disulfides as the pH drops more gradually toward neutrality. After dialysis, the protein 
was purified on a DEAE-Sepharose anion-exchange resin in 20 mM Tris buffer (pH 7.5) 
using a 0 M to 0.5 M NaCl gradient. Chromatography was monitored at 250 nm and 280 
nm, and fractions were collected based on these absorbance measurements. The protein 
was dialyzed against 10 mM ammonium bicarbonate following chromatography, dried 
and stored at -30 ˚C.  
Size-Exclusion Chromatography 
Size exclusion chromatography was used to resolve monomeric and dimeric 
species. The separation was performed on a Superdex 75 resin in 10 mM ammonium 
bicarbonate (5 cm diameter, 50 cm length column), and was monitored at 250 nm, 280 
nm, and 340 nm.  
Absorbance and Luminescence Spectroscopy 
 All spectroscopic analysis was performed in 10 mM Tris buffer (pH 8.2) 
containing 150 mM NaCl. For absorbance spectroscopy, 20 µM protein was analyzed 
using a 240 nm to 320 nm scan on a Perkin Elmer Lambda 45 UV/Vis Spectrometer. For 
luminescence spectroscopy, the emission spectra of a 1 µM protein sample was analyzed 
in a Perkin Elmer LS55 Luminescence Spectrometer from 300 nm to 400 nm upon 
excitation at 285 nm. 
SDS-PAGE Analysis 
 Sodium dodecyl sulfate polyacrylamide gel electrophoresis was performed in a 
Hoeffer SE600 large format apparatus using a 15% polyacrylamide gel. Samples were 
boiled in 3% SDS and 5% glycerol under reducing (2% 2-mercaptoethanol) or 
nonreducing (no 2-mercaptoethanool) conditions.  
Intact Mass Analysis 
 Protein samples were first purified by rp-HPLC on a peptide trap (Microchem 
BioResources) in 0.1% trifluoroacetic acid using stepwise additions of 0%, 50% and 90% 
acetonitrile. Fractions containing 50% and 90% acetonitrile were pooled and analyzed at 
the Ohio State University Campus Chemical Instrument Center Mass Spectrometry and 
Proteomics Facility using a Micromass Q-TOF II mass spectrometer. Injected sample was 
resolved by capillary rp-HPLC, then nanospray-ionized for quadrupole time-of-flight 
analysis. Sample mass was determined to ±2 Da precision. 
 
Digestion and Mass Analysis 
 Identification of specific residues participating in dimeric linkage was performed 
using previously determined experimental schemes [8, 9] involving enzymatic digestion 
followed by MS and tandem MS analysis. Proteins to be digested were solubilized in 10 
mM ammonium bicarbonate, then 20 mM iodoacetamide and 2 M urea were added (end 
concentrations) and the sample was incubated at room temp in darkness for at least 15 
minutes to alkylate free Cys residues and denature the protein. Digestion was performed 
using a 1:25 enzyme to substrate ratio at 37°C for 4 h or 20 h. 
 The masses of the resulting tryptic peptides were analyzed using matrix assisted 
laser desorption mass spectrometry and capillary rp-HPLC fed nanospray quadrupole 
time of flight tandem mass spectrometry on a Bruker Reflex III MALDI-TOF and a 
Micromass Q-TOF II, respectively. MALDI generated peak lists and MS/MS generated 
fragment ion data were analyzed using in house software (OSU CCIC MS and 
Proteomics Facility) or online software such as MASCOT [10] or Protein Prospector [11] 
to deduce sequence information. 
Results and Discussion 
Protein Folding Studies 
 Absorbance and luminescence spectra for monomeric wild-type prolactin, 
monomeric delta prolactin, and dimeric delta prolactin are compared in Figs 3 and 4. 
Each series is the average of three or more trials, and is normalized at 280nm and 340nm 
for absorbance and luminescence, respectively. Both spectra are good qualitative 
measures of the condition of a protein’s aromatic residues (Trp, Tyr, Phe) and in some 





Figure 3: Absorbance spectra for monomeric wild-type (WT, blue), monomeric delta (Mon, green), and dimeric delta (Dim, red) 
prolactin; spectra are normalized at 280nm, with raw spectra displayed in the inset.   
 
 
By analyzing a prolactin mutant’s 280nm / 250nm absorbance ratio, it is believed 
that one can deduce how well-folded the molecule is. Interestingly, dimeric delta 
prolactin displays a ratio that is intermediate between monomeric delta prolactin and 
monomeric wild-type prolactin. Dimeric delta prolactin was expected to yield 280nm / 
250nm ratio lower than monomeric delta prolactin; however this observation may 
actually indicate that the stress on the central disulfide often present in monomeric delta 
prolactin is no longer present, perhaps due to alternate disulfide formation. 
 Comparison of luminescence spectra between the aforementioned molecules was 
equally puzzling. Analysis of luminescence spectra is particularly useful for indicating 
the Trp residue environment: more polar environments stabilize excited Trp residues, 
thus a red shift in luminescence spectra is often indicative of Trp residues exposed to an 
Figure 4: Luminescence spectra for monomeric wild-type (WT, blue), monomeric delta (Mon, green), and dimeric delta 
(Dim, red) prolactin; spectra are normalized at 340nm, with raw spectra displayed in the inset.   
aqueous environment due to perturbed folding. Dimeric delta prolactin displays a distinct 
red shift when compared to wild-type prolactin, indicating relatively perturbed folding. 
Monomeric delta prolactin displays more red shift than dimeric prolactin, in addition to a 
unique increase in luminescence at 315nm, an area more indicative of Tyr condition. 
While Tyr residues are often quenched by nearby Trp residues, this increase may be due 
to fluorescence of a Tyr no longer nearby Trp residues. 
 Both dimeric and monomeric delta prolactin display absorbance and 
luminescence characteristics consistent with stressed structure. One can surmise that the 
12 residue deletion responsible for delta prolactin’s potent antagonism also puts intense 
stress on the molecule, and decreases the likelihood of properly folded molecules with 
properly paired disulfides. 
 
The Nature of Dimeric Delta Prolactin Linkage 
 Comparison of reducing and nonreducing SDS-PAGE is a robust indicator of 
protein purity and disulfide structure. For the purposes of this study, such a comparison is 
an excellent indicator of dimeric linkage type (Fig 5). 2-Mercaptoethanol is used to 
reduce proteins, essentially competing for constituent Cys residues of a disulfide bond. 
This results in two Cys residues each bound to 2-mercapto-ethanol rather than to each 
other. 
 Three samples of dimeric delta prolactin were analyzed by nonreducing and 
reducing SDS-PAGE. While samples in nonreducing conditions appear predominantly 
dimeric (~90%), the same samples appear predominantly monomeric (~90%) in reducing 
conditions. This is a very strong indicator that the linkage found in dimeric delta prolactin 
is an intermolecular disulfide bond, but 
it does not indicate between which 
residues this bond is formed.  
Intact mass analysis was 
performed on a mixture of purified 
monomeric and dimeric delta prolactin 
(Fig 6), using mass spectrometry. This 
analysis shows with great precision (± 2 
Da < 0.005% error) the masses of 
monomeric and dimeric delta prolactin, 
indicating that dimeric delta prolactin is 
composed solely of unmodified 
monomeric constituents. This data further 
implicates an intermolecular disulfide 
dimeric linkage. 








Figure 5: SDS-PAGE of dimeric delta prolactin 
samples under reducing and nonreducing conditions. 
Samples are indicated at the bottom of their 
corresponding lanes, with their conditions indicated 
above the sample number. 
 
 
Figure 6: Mass analysis of whole protein mixture of 
purified monomeric and dimeric delta prolactin; 
theoretical mass, calculated using sequence data, is  
21,583 Da per monomer; nanospray Q-TOF MS is 
precise to ± 2 Da. 
Key Residues Participating Dimeric Delta Prolactin Linkage 
 An experimental method was prepared using previous protocols in order to 
identify key residues participating in the intermolecular disulfide linkage found in 
dimeric delta prolactin. Digestion with the endopeptidase trypsin cleaves proteins at 
specific residues (Lys and Arg) resulting in a mixture of peptides of predicted sequence 
and mass. Tryptic digestion has particular utility in disulfide analysis. Tryptic digestion 
using nonreducing conditions can isolate disulfide-linked peptides – two tryptic peptides 
bound together by a disulfide bond. These are useful, because they allow us to identify 
which Cys residues are bound to each other by disulfide bonds. 
MALDI-TOF mass spectrometry yields the same type of mass analysis as 
nanospray Q-TOF, and differs only in the ionization method. MALDI is used is this case, 
because it is less sensitive to the presence of undesired ions (ie salts, buffers). Although 
observation of a peak of matching mass to a certain theoretical digest product is a strong 
indication of that product’s presence. Tandem mass spectrometry can be used to yield 
much more convincing results. 
Tandem mass spectrometry is performed on the Micromass Q-TOF II, but is more 
complex than the previously mentioned intact mass analysis. During tandem mass 
spectrometry, ionized sample molecules are first separated by mass (as before), then 
introduced into a collision cell where the stream of sample molecules is met with a 
perpendicular stream of inert argon. During this collision with argon, peptide samples 
fragment predictably at peptide bonds between the amino acid residues, from either n- or 
c- termini toward the center. Since this fragmentation pattern can be predicted, data 
obtained from tandem mass spectrometry can be compared to theoretical fragmentation 
patterns to yield sequence information. By analyzing the results of a tryptic digestion 
using mass spectrometry and tandem mass spectrometry, one can gain precise sequence 
details regarding which residues are responsible for the disulfide linkage in dimeric delta 
prolactin. 
Comparative analysis of monomeric and dimeric delta prolactin using the above 
experimental scheme yielded >80% sequence coverage for both samples. Since Cys 
containing peptides were the focus of our study, it is more important to determine which 
peptides were observed and which were not; all Cys containing peptides were observed in 
either unalkylated, alkylated, or disulfide linked form except peptide #1 (residues 1-10) 
containing Cys4. Careful analysis of tandem mass spectrometry fragment ion patterns in 
dimeric delta prolactin yielded a pattern with the following sequence: Arg-Leu-Thr-Val-
Gln-Cys-Cys-Gln (spectrum shown in Fig 7). This sequence is part of the theoretical 
Figure 7: Tandem Mass Spectrum of Cys11--Cys11 linked peptide found only in dimeric delta prolactin; 
Mass+H of linked peptide=1435.77 Da;  Mass+H of precursor ion = 479.27*3 = 1435.81 Da.   
tryptic peptide that results from Cys11--Cys11 linkage. The precursor ion had a 
mass/charge ratio of 479.27, which is consistent with the triply charged ion of the Cys11-
-Cys11 theoretical peptide (mass 1435.8 Da / charge 3+). Neither this sequence nor its 
precursor ion mass were observed in monomeric delta prolactin. 
From this sequence and precursor ion data, it is reasonable to assume that a 
disulfide bond exists between two Cys11 residues on different molecules, as one 
molecule of delta prolactin can only contain one Cys11. Therefore the linkage found in 
dimeric delta prolactin is likely an intermolecular disulfide bond between Cys11 residues. 
Final Conclusions and Future Research 
This insight into the nature of and key residues involved in dimeric linkage in 
delta prolactin allows us to now target intermolecular Cys11--Cys11 disulfide formation, 
and design new prolactin mutants that have improved folding characteristics. One 
possibility for new design would be truncation of the n-terminus, excluding the first 11 
residues, and removing Cys11 from the molecule entirely [2]. Such a molecule may be an 
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